FindTrial
Sign In

Initial pharmacological therapies for newly diagnosed, drugs naïve patients with type 2 diabetes

Initial pharmacological therapies for newly diagnosed, drugs naïve patients with type 2 diabetes - First-line therapy for T2DM

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000006860
Enrollment
30
Registered
2011-12-15
Start date
2010-01-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

T2DM

Interventions

several oral hypoglycmeic drugs diet/exercise

Sponsors

Biomedical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: hepatic/renal/cardiac/hypertensive disorder pregnant women

Exclusion criteria

Exclusion criteria: hepatic/renal/cardiac/hypertensive disorder pregnant women

Design outcomes

Primary

MeasureTime frame
HbA1, FBG,—

Secondary

MeasureTime frame
indexes for beta-cell function and insulin sensitivity, lipid parameters, body weight, blood pressure,—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026